98%
921
2 minutes
20
Objective: To evaluate the reporting quality of randomized controlled trials on acupuncture for the treatment of stable angina pectoris.
Methods: A systematic search was conducted in both Chinese and English databases, including CNKI, Wanfang, VIP, SinoMed, PubMed, Embase, Web of Science, and the Cochrane Library, with a focus on studies published from the inception of each database to March 4, 2025. This search aimed to identify clinical RCTs exploring the effectiveness of acupuncture in treating stable angina pectoris. The reporting quality of the included studies was assessed using the (Consolidated Statement for Trials) CONSORT statement and the (Standards for Reporting Interventions in Controlled Trials of Acupuncture) STRICTA guidelines. The CONSORT statement, an internationally recognized standard for trial reporting, was employed to evaluate the reporting quality of intervention measures in acupuncture trials, while the STRICTA guidelines were applied to assess acupuncture-specific reporting quality.
Results: A total of 31 studies were included in the analysis. The results from the CONSORT evaluation indicated that 19 items had a reporting rate of less than 10%, predominantly related to trial methods and results, while 4 items showed a reporting rate greater than 90%, mainly focusing on abstract descriptions, inclusion criteria, and subject recruitment. According to the STRICTA guidelines, the primary factors influencing the quality of acupuncture-related reports included the rationale for acupuncture treatment, the treatment setting, the description of acupuncturists, and the rationale for selecting control groups or control measures. The reporting rates for these factors were 32.26%, 3.23%, 6.45%, and 25.81%, respectively. In the final randomized controlled trials (RCTs) of acupuncture and moxibustion for stable angina pectoris (SAP), 31 items met the inclusion criteria. The overall reporting quality of these RCTs was suboptimal. Notably, 77.42% of studies failed to report essential intervention details, while a substantial proportion lacked definitions of primary outcomes or adequate descriptions of randomization and blinding procedures. These widespread reporting deficiencies reflect poor adherence to CONSORT and STRICTA guidelines, thereby compromising the transparency, methodological rigor, and interpretability of the current evidence base.
Conclusion: The overall reporting quality of literature on acupuncture for stable angina pectoris needs improvement. Future RCTs should strictly follow CONSORT and STRICTA to enhance research reliability and transparency.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401735 | PMC |
http://dx.doi.org/10.2147/JPR.S536468 | DOI Listing |
Curr Opin Cardiol
August 2025
National Heart and Lung Institute, Imperial College London.
Purpose Of Review: Symptom relief is now recognized as the primary remit of percutaneous coronary intervention (PCI) in patients with stable coronary artery disease. The relationship between the nature of angina symptoms and the likelihood of successful symptom relief from PCI had not been systematically studied until recently.
Recent Findings: The ORBITA-2 symptom-stratified analysis found that while the severity and nature of symptoms were poorly associated with the severity of coronary disease, the nature of the symptoms powerfully predicted the efficacy of PCI in relieving angina.
Diabetes Metab Syndr Obes
August 2025
Department of Endocrinology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, 450000, People's Republic of China.
Background: Chinese herbal medicines (CHMs) are used for type 2 diabetes mellitus combined with stable angina pectoris (T2DM-SAP), but their long-term effects lack real-world evidence.
Objective: To evaluate the effects of additional CHMs on angina readmission rates compared to standard treatment alone in patients with T2DM-SAP.
Methods: This retrospective cohort study included 704 patients with T2DM-SAP.
J Pain Res
August 2025
College of Acupuncture and Tuina, Changchun University of Traditional Chinese Medicine, Changchun, Jilin, People's Republic of China.
Objective: To evaluate the reporting quality of randomized controlled trials on acupuncture for the treatment of stable angina pectoris.
Methods: A systematic search was conducted in both Chinese and English databases, including CNKI, Wanfang, VIP, SinoMed, PubMed, Embase, Web of Science, and the Cochrane Library, with a focus on studies published from the inception of each database to March 4, 2025. This search aimed to identify clinical RCTs exploring the effectiveness of acupuncture in treating stable angina pectoris.
Am Heart J
August 2025
Cardiovascular Center Aalst, AZORG, Belgium; Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland. Electronic address:
Introduction: Coronary microvascular dysfunction (CMD) is increasingly recognized as an important cause of anginal symptoms and poor outcomes. Angina with non-obstructive coronary arteries (ANOCA) is often related to CMD. While physiological assessment of microcirculatory function by coronary bolus thermodilution is widely practiced, more precise and reproducible methodology as well as systematic assessment are necessary.
View Article and Find Full Text PDFLife (Basel)
August 2025
Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.
Non-ST-segment-elevation acute coronary syndrome (NSTE-ACS) often coexists with multivessel coronary artery disease (MVD), complicating treatment decisions. Current guidelines suggest complete revascularization (CR), yet robust evidence in hemodynamically stable patients remains insufficient. However, the comparative benefit of CR over incomplete revascularization (IR) in reducing ischemic events and improving cardiac function in this population is not well established.
View Article and Find Full Text PDF